A0A2R9BQM1 (A0A2R9BQM1_PANPA) Pan paniscus (Pygmy chimpanzee) (Bonobo)

Glycylpeptide N-tetradecanoyltransferase UniProtKBInterProSTRINGInteractive Modelling

496 aa; Sequence (Fasta) ; 4 identical sequences: Homo sapiens: P30419; Pongo abelii: A0A2J8UYT3; Pan troglodytes: A0A6D2WXT8, H2QD84

Available Structures

36 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
HsNMT1 in complex with CoA and Myristoylated-GCSVSKKK octapeptide
5o9u
 Heteromer
O81223; P30419; 		104-496
1×COA; 1×GOL; 1×MYR;
Assess
HsNMT1 in complex with CoA and Myristoylated-GGCFSKPK octapeptide
5o9v
 Heteromer
P30419; Q96NN9; 		104-496
1×COA; 3×GOL; 1×CL; 1×MYR;
Assess
HsNMT1 in complex with both MyrCoA and HCPA substrate peptide GKQNSKLR
7owm
 Heteromer
P30419; P84074; 		105-496
1×GOL; 1×MYA;
Assess
DeltaC3 C-terminal truncation of HsNMT1 in complex with MyrCoA and GDCFSKPR substrates
6sk8
 Heteromer
P30419; Q96NN9; 		102-493
1×MYA; 3×GOL; 1×CL;
Assess
HsNMT1 in complex with both MyrCoA and Acetylated-GKSFSKPR peptide reveals N-terminal Lysine Myrist…
6sk2
 Heteromer
P30419; Q96NN9; 		105-496
2×GOL; 1×COA; 1×MYR;
Assess
HsNMT1 in complex with both MyrCoA and Acetylated-GNCFSKPR substrates
6sjz
 Heteromer
P30419; Q96NN9; 		105-496
1×MYA; 1×CL; 2×GOL;
Assess
HsNMT1 in complex with both MyrCoA and GNCFSKRRAA substrates
6qrm
 Heteromer
P30419; Q96NN9; 		105-496
1×COA; 2×GOL; 1×CL; 1×MYR;
Assess
DeltaC2 C-terminal truncation of HsNMT1 in complex with MyrCoA and GNCFSKPR substrates
6skj
 Heteromer
P30419; Q96NN9; 		104-494
1×GOL; 1×MYA;
Assess
C-terminal HsNMT1 deltaC3 truncation in complex with both MyrCoA and GNCFSKPR substrates
6sk3
 Heteromer
P30419; Q96NN9; 		104-493
1×GOL; 1×MYA;
Assess
HsNMT1 in complex with CoA and Myristoylated-GKSNSKLK octapeptide
5o9s
 Heteromer
P30419; P62166; 		115-496
2×GOL; 1×CL; 1×MYR;
Assess
Structure of Human NMT1 with products CoA and myristoyl-lysine peptide with acetylated N-terminus
6pav
 Heteromer
P30419; P62330; 		116-496
2×COA; 4×GOL; 2×MYR;
Assess
Crystal structure of human N-myristoyltransferase 1 fragment (residues 109-496) bound to diacylated…
7rk3
 Heteromer
P30419; P62330; 		145-496
1×4PS; 1×MYR; 1×6NA;
Assess
Mutant of Human N-myristoyltransferase with bound myristoyl-CoA
6f56
homo-4-mer115-496
4×MYA; 4×MG; 9×GOL;
Assess
HsNMT1 in complex with both MyrCoA and ACE-G-(L-ORN)SFSKPR
7owp
monomer103-496
1×GOL; 1×MYA;
Assess
HsNMT1 in complex with both MyrCoA and peptide AKSFSKPR
7own
monomer104-496
2×GOL; 1×MYA;
Assess
HsNMT1 in complex with both MyrCoA and N-acetylated KSFSKPR peptide
7owo
monomer105-496
1×GOL; 1×COA; 1×MYA; 1×MYR;
Assess
HsNMT1 in complex with CoA and acetylated-NCFSKPK peptide
5o9t
monomer105-496
1×MYA; 2×GOL; 1×CL;
Assess
HsNMT1 in complex with both CoA and Myr-ANCFSKPR peptide
7owu
monomer106-496
1×COA; 2×GOL; 1×MYR;
Assess
HsNMT1 in complex with both MyrCoA and peptide GGKSFSKPR
7owr
monomer106-496
1×GOL; 1×MYA;
Assess
HsNMT1 in complex with both MyrCoA and peptide N-Methylated-GNCFSKPR
7owq
monomer106-496
1×MYA;
Assess
Human NMT1 in complex with myristoyl-CoA and inhibitor IMP-917
5o6h
monomer115-496
1×MYA; 3×PO4; 1×9M2; 1×MG; 1×GOL; 1×DMS;
Assess
Crystal Structure of human type-I N-myristoyltransferase with bound myristoyl-CoA
3iu1
monomer115-496
1×MYA;
Assess
Human NMT1 in complex with myristoyl-CoA and inhibitor IMP-1031
5o6j
monomer115-496
1×MYA; 3×PO4; 1×MG; 1×9M8;
Assess
Crystal Structure of human type-I N-myristoyltransferase with bound myristoyl-CoA and inhibitor DDD…
3jtk
monomer115-496
1×MYA; 1×X55;
Assess
Human N-myristoyltransferase (NMT1) with Myristoyl-CoA co-factor
4c2y
monomer115-496
1×MYA; 1×MG; 1×CIT; 3×GOL;
Assess
Crystal Structure of human type-I N-myristoyltransferase with bound myristoyl-CoA and inhibitor DDD…
3iu2
monomer115-496
1×MYA; 1×096;
Assess
Crystal Structure of human type-I N-myristoyltransferase with bound myristoyl-CoA and inhibitor DDD…
3iwe
monomer115-496
1×MYA; 1×646;
Assess
Human N-myristoyltransferase (NMT1) with Myristoyl-CoA and IMP-1088 inhibitor bound
5mu6
monomer115-496
1×MYA; 1×MG; 2×GOL; 1×KFK;
Assess
Human N-myristoyltransferase (NMT1) with Myristoyl-CoA and inhibitor bound
6fz5
monomer115-496
1×BXN; 1×MYA; 1×MG; 2×GOL;
Assess
Human N-myristoyltransferase (NMT1) with Myristoyl-CoA and inhibitor bound
6fz3
monomer115-496
1×EBK; 1×MYA; 1×MG; 1×GOL;
Assess
Human N-myristoyltransferase (NMT1) with Myristoyl-CoA and inhibitor bound
4c2z
monomer115-496
1×MYA; 1×646; 1×MG; 1×CIT; 2×GOL; 3×CL;
Assess
Human N-myristoyltransferase (NMT1) with Myristoyl-CoA and peptide bound
6ehj
monomer115-496
2×GOL; 1×MYA; 1×GLY; 2×SER; 1×ASN; 3×LYS; 1×PRO; 1×MYR; 1×COA;
Assess
N-myristoyltransferase 1 (NMT) bound to myristoyl-CoA
5uut
monomer115-496
1×MYA; 1×CIT;
Assess
Human N-myristoyltransferase 1 (MNT1) with Myristoyl-CoA analogue X10 bound
5npq
monomer115-496
2×GOL; 1×94Q; 1×MG;
Assess
Human N-myristoyltransferase (NMT1) with Myristoyl-CoA and inhibitor bound
6fz2
monomer116-496
1×31A; 1×MYA; 1×MG; 1×GOL;
Assess
Crystal structure of human myristoyl-CoA:protein N-myristoyltransferase.
1rxt
monomer155-496
2×SO4;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
5o9v.2.Amonomer0.90104-496
1×GLY; 1×COA;100.00
Assess